Lilly paid 1.6 Billion for a cancer drug, which just failed.

https://endpts.com/eli-lillys-first-phiii-sho...-what-now/

This is horrible news -- I was hoping that there would finally be a drug that would help against pancreatic cancer.

However, it does show what Kevetrin is really worth. It's a lot more than the market cap for the company now.

Just think, little bashers, what if there is a deal like this for Kevetrin? What will happen to your short positions then?